ptdser mrfp lact c2 biosensors (Addgene inc)
Addgene inc is a verified supplier 
93
Structured Review
Addgene inc
ptdser mrfp lact c2 biosensors
Ptdser Mrfp Lact C2 Biosensors, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 12 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/er+mrfp/ER-mRFP+(Plasmid+%2362236)/pmc11982563-562-6-11
Average 93 stars, based on 12 article reviews
Ptdser Mrfp Lact C2 Biosensors, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 12 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/er+mrfp/ER-mRFP+(Plasmid+%2362236)/pmc11982563-562-6-11
Average 93 stars, based on 12 article reviews
ptdser mrfp lact c2 biosensors - by Bioz Stars,
2026-10
93/100 stars
Images
Related Articles
Sequencing:Article Title: Targeting Cholesterol Biosynthesis with Statins Synergizes with AKT Inhibitors in Triple-Negative Breast Cancer Article Snippet: The following 444 primers were generated using Agilent’s QuikChange Primer Design tool: H866A: 5’445 CAGGACATCTTGTCAAAAGTGCCATGATTCACAACAGGTCGA-3’ (forward), 5’446 TCGACCTGTTGTGAATCATGGCACTTTTGACAAGATGTCCTG-3’ (reverse), E559A: 5’447 CCAATGGCAACAACAGCAGGTTGTCTTGTGGCC-3’ (forward), 5’448 GGCCACAAGACAACCTGCTGTTGTTGCCATTGG-3’ (reverse), K691A: 5’449 GTTAGTGGTAACTATTGTACTGACGCGAAACCTGCTGCTATAAATTGGAT-3’ (forward), 5’450 ATCCAATTTATAGCAGCAGGTTTCGCGTCAGTACAATAGTTACCACTAAC-3’ (reverse), D767A: 5’451 CATTGCCTGTGGACAGGCTGCAGCACAGAATGTTG-3’ (forward), 5’452 CAACATTCTGTGCTGCAGCCTGTCCACAGGCAATG-3’ (reverse). .. To generate pLenti6-ER-mRFP, 453 mRFP with a C-terminal KDEL sequence (ER-mRFP) was PCR amplified out of Article Title: Targeting Cholesterol Biosynthesis with Statins Synergizes with AKT Inhibitors in Triple-Negative Breast Cancer Article Snippet: The following primers were generated using Agilent’s QuikChange Primer Design tool: H866A: 5′-CAG GAC ATC TTG TCA AAA GTG CCA TGA TTC ACA ACA GGT CGA-3′ (forward), 5′-TCG ACC TGT TGT GAA TCA TGG CAC TTT TGA CAA GAT GTC CTG-3′ (reverse), E559A: 5′-CCA ATG GCA ACA ACA GCA GGT TGT CTT GTG GCC-3′ (forward), 5′-GGC CAC AAG ACA ACC TGC TGT TGT TGC CAT TGG-3′ (reverse), K691A: 5′-GTT AGT GGT AAC TAT TGT ACT GAC GCG AAA CCT GCT GCT ATA AAT TGG AT-3′ (forward), 5′-ATC CAA TTT ATA GCA GCA GGT TTC GCG TCA GTA CAA TAG TTA CCA CTA AC-3′ (reverse), D767A: 5′-CAT TGC CTG TGG ACA GGC TGC AGC ACA GAA TGT TG-3′ (forward), 5′-CAA CAT TCT GTG CTG CAG CCT GTC CAC AGG CAA TG-3′ (reverse). .. To generate pLenti6-ER-mRFP, mRFP with a C-terminal KDEL sequence (ER-mRFP) was PCR amplified out of Article Title: Cholesterol biosynthesis inhibition synergizes with AKT inhibitors in triple-negative breast cancer Article Snippet: The following primers were generated using Agilent’s QuikChange Primer Design tool: H866A: 5’- CAGGACATCTTGTCAAAAGTGCCATGATTCACAACAGGTCGA-3’ (forward), 5’- TCGACCTGTTGTGAATCATGGCACTTTTGACAAGATGTCCTG-3’ (reverse), E559A: 5’- CCAATGGCAACAACAGCAGGTTGTCTTGTGGCC-3’ (forward), 5’- GGCCACAAGACAACCTGCTGTTGTTGCCATTGG-3’ (reverse), K691A: 5’- GTTAGTGGTAACTATTGTACTGACGCGAAACCTGCTGCTATAAATTGGAT-3’ (forward), 5’- ATCCAATTTATAGCAGCAGGTTTCGCGTCAGTACAATAGTTACCACTAAC-3’ (reverse), D767A: 5’- CATTGCCTGTGGACAGGCTGCAGCACAGAATGTTG-3’ (forward), 5’- CAACATTCTGTGCTGCAGCCTGTCCACAGGCAATG-3’ (reverse). .. To generate pLenti6-ER-mRFP, mRFP with a C-terminal KDEL sequence (ER-mRFP) was PCR amplified out of Polymerase Chain Reaction:Article Title: Targeting Cholesterol Biosynthesis with Statins Synergizes with AKT Inhibitors in Triple-Negative Breast Cancer Article Snippet: The following 444 primers were generated using Agilent’s QuikChange Primer Design tool: H866A: 5’445 CAGGACATCTTGTCAAAAGTGCCATGATTCACAACAGGTCGA-3’ (forward), 5’446 TCGACCTGTTGTGAATCATGGCACTTTTGACAAGATGTCCTG-3’ (reverse), E559A: 5’447 CCAATGGCAACAACAGCAGGTTGTCTTGTGGCC-3’ (forward), 5’448 GGCCACAAGACAACCTGCTGTTGTTGCCATTGG-3’ (reverse), K691A: 5’449 GTTAGTGGTAACTATTGTACTGACGCGAAACCTGCTGCTATAAATTGGAT-3’ (forward), 5’450 ATCCAATTTATAGCAGCAGGTTTCGCGTCAGTACAATAGTTACCACTAAC-3’ (reverse), D767A: 5’451 CATTGCCTGTGGACAGGCTGCAGCACAGAATGTTG-3’ (forward), 5’452 CAACATTCTGTGCTGCAGCCTGTCCACAGGCAATG-3’ (reverse). .. To generate pLenti6-ER-mRFP, 453 mRFP with a C-terminal KDEL sequence (ER-mRFP) was PCR amplified out of Article Title: Targeting Cholesterol Biosynthesis with Statins Synergizes with AKT Inhibitors in Triple-Negative Breast Cancer Article Snippet: The following primers were generated using Agilent’s QuikChange Primer Design tool: H866A: 5′-CAG GAC ATC TTG TCA AAA GTG CCA TGA TTC ACA ACA GGT CGA-3′ (forward), 5′-TCG ACC TGT TGT GAA TCA TGG CAC TTT TGA CAA GAT GTC CTG-3′ (reverse), E559A: 5′-CCA ATG GCA ACA ACA GCA GGT TGT CTT GTG GCC-3′ (forward), 5′-GGC CAC AAG ACA ACC TGC TGT TGT TGC CAT TGG-3′ (reverse), K691A: 5′-GTT AGT GGT AAC TAT TGT ACT GAC GCG AAA CCT GCT GCT ATA AAT TGG AT-3′ (forward), 5′-ATC CAA TTT ATA GCA GCA GGT TTC GCG TCA GTA CAA TAG TTA CCA CTA AC-3′ (reverse), D767A: 5′-CAT TGC CTG TGG ACA GGC TGC AGC ACA GAA TGT TG-3′ (forward), 5′-CAA CAT TCT GTG CTG CAG CCT GTC CAC AGG CAA TG-3′ (reverse). .. To generate pLenti6-ER-mRFP, mRFP with a C-terminal KDEL sequence (ER-mRFP) was PCR amplified out of Article Title: Cholesterol biosynthesis inhibition synergizes with AKT inhibitors in triple-negative breast cancer Article Snippet: The following primers were generated using Agilent’s QuikChange Primer Design tool: H866A: 5’- CAGGACATCTTGTCAAAAGTGCCATGATTCACAACAGGTCGA-3’ (forward), 5’- TCGACCTGTTGTGAATCATGGCACTTTTGACAAGATGTCCTG-3’ (reverse), E559A: 5’- CCAATGGCAACAACAGCAGGTTGTCTTGTGGCC-3’ (forward), 5’- GGCCACAAGACAACCTGCTGTTGTTGCCATTGG-3’ (reverse), K691A: 5’- GTTAGTGGTAACTATTGTACTGACGCGAAACCTGCTGCTATAAATTGGAT-3’ (forward), 5’- ATCCAATTTATAGCAGCAGGTTTCGCGTCAGTACAATAGTTACCACTAAC-3’ (reverse), D767A: 5’- CATTGCCTGTGGACAGGCTGCAGCACAGAATGTTG-3’ (forward), 5’- CAACATTCTGTGCTGCAGCCTGTCCACAGGCAATG-3’ (reverse). .. To generate pLenti6-ER-mRFP, mRFP with a C-terminal KDEL sequence (ER-mRFP) was PCR amplified out of Amplification:Article Title: Targeting Cholesterol Biosynthesis with Statins Synergizes with AKT Inhibitors in Triple-Negative Breast Cancer Article Snippet: The following 444 primers were generated using Agilent’s QuikChange Primer Design tool: H866A: 5’445 CAGGACATCTTGTCAAAAGTGCCATGATTCACAACAGGTCGA-3’ (forward), 5’446 TCGACCTGTTGTGAATCATGGCACTTTTGACAAGATGTCCTG-3’ (reverse), E559A: 5’447 CCAATGGCAACAACAGCAGGTTGTCTTGTGGCC-3’ (forward), 5’448 GGCCACAAGACAACCTGCTGTTGTTGCCATTGG-3’ (reverse), K691A: 5’449 GTTAGTGGTAACTATTGTACTGACGCGAAACCTGCTGCTATAAATTGGAT-3’ (forward), 5’450 ATCCAATTTATAGCAGCAGGTTTCGCGTCAGTACAATAGTTACCACTAAC-3’ (reverse), D767A: 5’451 CATTGCCTGTGGACAGGCTGCAGCACAGAATGTTG-3’ (forward), 5’452 CAACATTCTGTGCTGCAGCCTGTCCACAGGCAATG-3’ (reverse). .. To generate pLenti6-ER-mRFP, 453 mRFP with a C-terminal KDEL sequence (ER-mRFP) was PCR amplified out of Article Title: Targeting Cholesterol Biosynthesis with Statins Synergizes with AKT Inhibitors in Triple-Negative Breast Cancer Article Snippet: The following primers were generated using Agilent’s QuikChange Primer Design tool: H866A: 5′-CAG GAC ATC TTG TCA AAA GTG CCA TGA TTC ACA ACA GGT CGA-3′ (forward), 5′-TCG ACC TGT TGT GAA TCA TGG CAC TTT TGA CAA GAT GTC CTG-3′ (reverse), E559A: 5′-CCA ATG GCA ACA ACA GCA GGT TGT CTT GTG GCC-3′ (forward), 5′-GGC CAC AAG ACA ACC TGC TGT TGT TGC CAT TGG-3′ (reverse), K691A: 5′-GTT AGT GGT AAC TAT TGT ACT GAC GCG AAA CCT GCT GCT ATA AAT TGG AT-3′ (forward), 5′-ATC CAA TTT ATA GCA GCA GGT TTC GCG TCA GTA CAA TAG TTA CCA CTA AC-3′ (reverse), D767A: 5′-CAT TGC CTG TGG ACA GGC TGC AGC ACA GAA TGT TG-3′ (forward), 5′-CAA CAT TCT GTG CTG CAG CCT GTC CAC AGG CAA TG-3′ (reverse). .. To generate pLenti6-ER-mRFP, mRFP with a C-terminal KDEL sequence (ER-mRFP) was PCR amplified out of Article Title: Cholesterol biosynthesis inhibition synergizes with AKT inhibitors in triple-negative breast cancer Article Snippet: The following primers were generated using Agilent’s QuikChange Primer Design tool: H866A: 5’- CAGGACATCTTGTCAAAAGTGCCATGATTCACAACAGGTCGA-3’ (forward), 5’- TCGACCTGTTGTGAATCATGGCACTTTTGACAAGATGTCCTG-3’ (reverse), E559A: 5’- CCAATGGCAACAACAGCAGGTTGTCTTGTGGCC-3’ (forward), 5’- GGCCACAAGACAACCTGCTGTTGTTGCCATTGG-3’ (reverse), K691A: 5’- GTTAGTGGTAACTATTGTACTGACGCGAAACCTGCTGCTATAAATTGGAT-3’ (forward), 5’- ATCCAATTTATAGCAGCAGGTTTCGCGTCAGTACAATAGTTACCACTAAC-3’ (reverse), D767A: 5’- CATTGCCTGTGGACAGGCTGCAGCACAGAATGTTG-3’ (forward), 5’- CAACATTCTGTGCTGCAGCCTGTCCACAGGCAATG-3’ (reverse). .. To generate pLenti6-ER-mRFP, mRFP with a C-terminal KDEL sequence (ER-mRFP) was PCR amplified out of Generated:Article Title: Motion of single molecular tethers reveals dynamic subdomains at ER-mitochondria contact sites Article Snippet: .. Article Title: Motion of VAPB molecules reveals ER–mitochondria contact site subdomains Article Snippet: .. Article Title: Motion of VAPB molecules reveals ER-mitochondria contact site subdomains. Article Snippet: .. |